Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

This activity is part 1 of a 4-part curriculum.

Program Description
This module is designed to enhance pharmacists' understanding of the risk factors and substantial burden that respiratory syncytial virus (RSV) places on older adults. It will delve into the specific challenges associated with managing this acute respiratory infection in a vulnerable population and the severity of complications, including severe respiratory distress, hospitalization, and increased mortality rates. Pharmacists will gain insights into the physical, emotional, and psychological impact of RSV on older adults. By understanding the multifaceted nature of RSV in older adults, pharmacists will be better equipped to optimize patient care, reduce complications, and improve quality of life for this vulnerable population.

Target audience: Pharmacy technicians
Type of activity: Knowledge
Release date: February 28, 2025
Expiration date: February 28, 2026
Learner level: Foundational
Time to complete activity: 0.5 hour
Fee: Free

Educational Objective

At the completion of this activity, participants will be able to:

• Recall the risk factors, disease burden, and complications associated with respiratory syncytial virus infection in older adults

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity numbers 0290-0000-25-004-H06-P and 0290-0000-25-004-H06-T. The activity is available for CE credit through February 28, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Faculty

Miranda Wilhelm, PharmD, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Adam C. Welch, PharmD, MBA, FAPhA; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

Medical reviewer Paul M. Boylan, PharmD, BCPS, has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Pfizer Inc
Stock: Lilly

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/term